Here, we show the remarkable synergy of vasculature‐targeted AFR therapy with mCD8‐AFN, targeting cytotoxic T cells (and the cDC1 subset of DCs), leading to profound B16Bl6 tumor elimination. The gene discussed is MPPE1; the disease is neoplasm.